Pharming Group Finishes Enrolling Patients for Phase 3 Pediatric Testing of Its Treatment for Rare Auto-Immune Disorder
Pharming Group Finishes Enrolling Patients for Phase 3 Pediatric Testing of Its Treatment for Rare Auto-Immune Disorder
药明集团完成其罕见自身免疫性疾病治疗的3期儿科测试的患者注册
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册